410 related articles for article (PubMed ID: 15114602)
21. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.
Auerbach M; Al Talib K
Kidney Int; 2008 Mar; 73(5):528-30. PubMed ID: 18274543
[TBL] [Abstract][Full Text] [Related]
22. [Parenteral iron therapy: problems and possible solutions].
Hoigné R; Breymann C; Künzi UP; Brunner F
Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
[TBL] [Abstract][Full Text] [Related]
23. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
24. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
[TBL] [Abstract][Full Text] [Related]
25. Is iron gluconate really safer than iron dextran?
Eichbaum Q; Foran S; Dzik S
Blood; 2003 May; 101(9):3756-7. PubMed ID: 12707229
[No Abstract] [Full Text] [Related]
26. Clinical update: intravenous iron for anaemia.
Auerbach M; Ballard H; Glaspy J
Lancet; 2007 May; 369(9572):1502-1504. PubMed ID: 17482969
[No Abstract] [Full Text] [Related]
27. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Wang C; Graham DJ; Kane RC; Xie D; Wernecke M; Levenson M; MaCurdy TE; Houstoun M; Ryan Q; Wong S; Mott K; Sheu TC; Limb S; Worrall C; Kelman JA; Reichman ME
JAMA; 2015 Nov; 314(19):2062-8. PubMed ID: 26575062
[TBL] [Abstract][Full Text] [Related]
28. Achieving target hematocrit in dialysis patients: new concepts in iron management.
Nissenson AR
Am J Kidney Dis; 1997 Dec; 30(6):907-11. PubMed ID: 9398140
[TBL] [Abstract][Full Text] [Related]
29. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products.
Charytan C; Schwenk MH; Al-Saloum MM; Spinowitz BS
Nephron Clin Pract; 2004; 96(2):c63-6. PubMed ID: 14988600
[TBL] [Abstract][Full Text] [Related]
30. Response to iron sucrose in dialysis patients sensitive to iron dextran.
Gupta A; Khaira A; Dogra M; Agarwal SK
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):744-5; author reply 745. PubMed ID: 20587886
[No Abstract] [Full Text] [Related]
31. Anaphylactoid reaction to intravenous sodium ferric gluconate complex during pregnancy.
Cuciti C; Mayer DC; Arnette R; Spielman FJ
Int J Obstet Anesth; 2005 Oct; 14(4):362-4. PubMed ID: 16140521
[TBL] [Abstract][Full Text] [Related]
32. [Indications and practical management of parenteral iron therapy].
Kosch M; Schaefer RM
Wien Klin Wochenschr; 2003 Jun; 115(11):380-4. PubMed ID: 12879735
[TBL] [Abstract][Full Text] [Related]
33. Intravenous iron in a primary-care clinic.
Maslovsky I
Am J Hematol; 2005 Apr; 78(4):261-4. PubMed ID: 15795917
[TBL] [Abstract][Full Text] [Related]
34. Parenteral iron therapy.
Kaplinsky C
Isr Med Assoc J; 2008 May; 10(5):372-3. PubMed ID: 18605363
[No Abstract] [Full Text] [Related]
35. Hypersensitivity reactions and deaths associated with intravenous iron preparations.
Bailie GR; Clark JA; Lane CE; Lane PL
Nephrol Dial Transplant; 2005 Jul; 20(7):1443-9. PubMed ID: 15855210
[TBL] [Abstract][Full Text] [Related]
36. Use of intravenous iron supplementation in chronic kidney disease: an update.
Macdougall IC; Geisser P
Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
[TBL] [Abstract][Full Text] [Related]
37. Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.
Prakash S; Walele A; Dimkovic N; Bargman J; Vas S; Oreopoulos D
Perit Dial Int; 2001; 21(3):290-5. PubMed ID: 11475345
[TBL] [Abstract][Full Text] [Related]
38. [Iron deficiency. When parenteral substitution?].
Kosch M; Schaefer RM
MMW Fortschr Med; 2001 Feb; 143(6):38-9. PubMed ID: 11247361
[No Abstract] [Full Text] [Related]
39. Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran.
Bastani B; Rahman S; Gellens M
ASAIO J; 2002; 48(4):404-6. PubMed ID: 12141472
[TBL] [Abstract][Full Text] [Related]
40. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
